Bank of America’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-14,730
| Closed | -$37K | – | 7411 |
|
|
2020
Q2 | $37K | Buy |
14,730
+3,779
| +35% | +$7.16K | ﹤0.01% | 6100 |
|
|
2020
Q1 | $14K | Buy |
10,951
+3,852
| +54% | +$7.86K | ﹤0.01% | 6279 |
|
|
2019
Q4 | $20K | Buy |
7,099
+1,611
| +29% | +$5.17K | ﹤0.01% | 6508 |
|
|
2019
Q3 | $29K | Sell |
5,488
-13,408
| -71% | -$89.3K | ﹤0.01% | 6499 |
|
|
2019
Q2 | $181K | Buy |
18,896
+8,219
| +77% | +$151K | ﹤0.01% | 5693 |
|
|
2019
Q1 | $286K | Buy |
10,677
+3,538
| +50% | +$90K | ﹤0.01% | 5342 |
|
|
2018
Q4 | $161K | Buy |
7,139
+429
| +6% | +$16.8K | ﹤0.01% | 5656 |
|
|
2018
Q3 | $371K | Buy |
6,710
+5,845
| +676% | +$373K | ﹤0.01% | 5141 |
|
|
2018
Q2 | $62K | Buy |
865
+280
| +48% | +$19.8K | ﹤0.01% | 6033 |
|
|
2018
Q1 | $36K | Sell |
585
-389
| -40% | -$34.1K | ﹤0.01% | 6177 |
|
|
2017
Q4 | $122K | Buy |
974
+616
| +172% | +$78.9K | ﹤0.01% | 5663 |
|
|
2017
Q3 | $49K | Buy |
358
+108
| +43% | +$14.4K | ﹤0.01% | 5962 |
|
|
2017
Q2 | $35K | Sell |
250
-333
| -57% | -$51.5K | ﹤0.01% | 6023 |
|
|
2017
Q1 | $107K | Sell |
583
-15
| -3% | -$1.68K | ﹤0.01% | 5593 |
|
|
2016
Q4 | $48K | Buy |
598
+211
| +55% | +$16.7K | ﹤0.01% | 5953 |
|
|
2016
Q3 | $30K | Sell |
387
-233
| -38% | -$18.7K | ﹤0.01% | 5965 |
|
|
2016
Q2 | $54K | Buy |
620
+290
| +88% | +$26.6K | ﹤0.01% | 5803 |
|
|
2016
Q1 | $30K | Sell |
330
-738
| -69% | -$73.7K | ﹤0.01% | 5981 |
|
|
2015
Q4 | $214K | Sell |
1,068
-4,028
| -79% | -$804K | ﹤0.01% | 5340 |
|
|
2015
Q3 | $760K | Buy |
5,096
+4,838
| +1,875% | +$3.55M | ﹤0.01% | 4528 |
|
|
2015
Q2 | $246K | Buy |
258
+238
| +1,190% | +$195K | ﹤0.01% | 5135 |
|
|
2015
Q1 | $15K | Sell |
20
-1,000
| -98% | -$751K | ﹤0.01% | 6170 |
|
|
2014
Q4 | $811K | Sell |
1,020
-114
| -10% | -$61.4K | ﹤0.01% | 4222 |
|
|
2014
Q3 | $452K | Sell |
1,134
-21
| -2% | -$5.62K | ﹤0.01% | 4682 |
|
|
2014
Q2 | $312K | Sell |
1,155
-5,260
| -82% | -$1.13M | ﹤0.01% | 5094 |
|
|
2014
Q1 | $1.4M | Buy |
6,415
+6,388
| +23,659% | +$1.78M | ﹤0.01% | 3568 |
|
|
2013
Q4 | $8K | Sell |
27
-7
| -21% | -$1.67K | ﹤0.01% | 7369 |
|
|
2013
Q3 | $8K | Sell |
34
-771
| -96% | -$135K | ﹤0.01% | 7259 |
|
|
2013
Q2 | $114K | Buy |
+805
| New | +$127K | ﹤0.01% | 6087 |
|
Bank of America's TTPH Position: Q3 2020 in Review
Bank of America sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2020, closing a stake of 14,730 shares — an estimated $37K sold.
Bank of America first reported a position in TTPH in Q2 2013 and held it in 29 quarters. The position peaked at $1.4M in Q1 2014. 1 fund tracked by Wall St. Rank holds TTPH as of Q3 2020.
- Bank of America reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Bank of America sold 14,730 Tetraphase Pharmaceuticals, Inc. shares in Q3 2020, an estimated $37K.
- Bank of America first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 29 quarters.
- Bank of America's Tetraphase Pharmaceuticals, Inc. position peaked at $1.4M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2020.
Based on Bank of America's 13F filing for Q3 2020, filed 13 Nov 2020.